Bioethics, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 19, 2021 at 12:12 pm EST
Share
Bioethics, Ltd. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 0.025706 million compared to USD 0.024052 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
For the nine months, net loss was USD 0.083764 million compared to USD 0.088423 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.08 a year ago.
Bioethics, Ltd. is a shell company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company has not commenced any operations nor generated any revenue.
BIOETHICS, LTD. 
